|
BI-RADS classification
|
Isolated DCIS
|
IDC-DCIS
|
Isolated-IDC
|
Isolated ILC
|
Other tumours
|
Total
|
---|
Diagnostic imaging
| |
N (%)
|
N (%)
|
N (%)
|
N (%)
|
N (%)
|
N (%)
|
---|
Sonography
|
0
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
|
1
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
|
2
|
0 (0%)
|
0 (0%)
|
0 (%)
|
0 (0%)
|
1 (11.1%)
|
1 (0.8%)
|
|
3
|
0 (0%)
|
0 (0%)
|
3 (7.3%)
|
0 (0%)
|
0 (0%)
|
3 (2.5%)
|
|
4
|
10 (66.7%)
|
17 (44.8%)
|
10 (24.4%)
|
8 (44.4%)
|
5 (55.6%)
|
50 (41.3%)
|
|
5
|
5 (33.3%)
|
20 (52.6%)
|
28 (68.3%)
|
10 (55.6%)
|
3 (33.3%)
|
66 (54.5%)
|
|
6
|
0 (0%)
|
1 (2.6%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
1 (0.8%)
|
Mammography
|
0
|
0 (0%)
|
1 (2.6%)
|
0 (0%)
|
1 (5.6%)
|
0 (0%)
|
2 (1.7%)
|
|
1
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
|
2
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
|
3
|
1 (6.7%)
|
4 (10.5%)
|
3 (7.3%)
|
0 (0%)
|
1 (11.1%)
|
9 (7.4%)
|
|
4
|
1 (6.7%)
|
12 (31.6%)
|
17 (41.5%)
|
11 (61.1%)
|
5 (55.6%)
|
46 (38.0%)
|
|
5
|
13 (86.6%)
|
19 (50%)
|
17 (41.5)
|
6 (33.3%)
|
3 (33.3%)
|
58 (47.9%)
|
|
6
|
0 (0%)
|
2 (5.3%)
|
4 (9.7%)
|
0 (0%)
|
0 (0%)
|
6 (5.0%)
|
MRI
|
0
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
|
1
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
|
2
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
|
3
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (%)
|
0 (0%)
|
0 (0%)
|
|
4
|
0 (0%)
|
2 (5.3%)
|
4 (9.8%)
|
0 (0%)
|
0 (0%)
|
7 (5.8%)
|
|
5
|
9 (60%)
|
22 (57.9%)
|
26 (63.4%)
|
8 (44.4%)
|
3 (33.3%)
|
68 (56.2%)
|
|
6
|
6 (40%)
|
14 (36.8%)
|
11 (26.8%)
|
9 (50%)
|
6 (66.7%)
|
46 (38.0%)
|
-
DCIS Ductal carcinoma in situ, IDC Invasive ductal carcinoma, ILC Invasive lobular carcinoma.